These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26894433)

  • 1. Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients.
    Schottlaender LV; Bettencourt C; Kiely AP; Chalasani A; Neergheen V; Holton JL; Hargreaves I; Houlden H
    PLoS One; 2016; 11(2):e0149557. PubMed ID: 26894433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum.
    Barca E; Kleiner G; Tang G; Ziosi M; Tadesse S; Masliah E; Louis ED; Faust P; Kang UJ; Torres J; Cortes EP; Vonsattel JP; Kuo SH; Quinzii CM
    J Neuropathol Exp Neurol; 2016 Jul; 75(7):663-72. PubMed ID: 27235405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations.
    Ozawa T; Paviour D; Quinn NP; Josephs KA; Sangha H; Kilford L; Healy DG; Wood NW; Lees AJ; Holton JL; Revesz T
    Brain; 2004 Dec; 127(Pt 12):2657-71. PubMed ID: 15509623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grading of neuropathology in multiple system atrophy: proposal for a novel scale.
    Jellinger KA; Seppi K; Wenning GK
    Mov Disord; 2005 Aug; 20 Suppl 12():S29-36. PubMed ID: 16092088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Coenzyme Q10 Levels in Patients With Multiple System Atrophy.
    Mitsui J; Matsukawa T; Yasuda T; Ishiura H; Tsuji S
    JAMA Neurol; 2016 Aug; 73(8):977-80. PubMed ID: 27356913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlates of decreased plasma coenzyme Q10 levels in patients with multiple system atrophy.
    Du J; Wang T; Huang P; Cui S; Gao C; Lin Y; Fu R; Shen J; He Y; Tan Y; Chen S
    Parkinsonism Relat Disord; 2018 Dec; 57():58-62. PubMed ID: 30093363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson's disease.
    Foti SC; Hargreaves I; Carrington S; Kiely AP; Houlden H; Holton JL
    Sci Rep; 2019 Apr; 9(1):6559. PubMed ID: 31024027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy.
    Nakamoto FK; Okamoto S; Mitsui J; Sone T; Ishikawa M; Yamamoto Y; Kanegae Y; Nakatake Y; Imaizumi K; Ishiura H; Tsuji S; Okano H
    Sci Rep; 2018 Sep; 8(1):14215. PubMed ID: 30242188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy.
    Kasai T; Tokuda T; Ohmichi T; Ishii R; Tatebe H; Nakagawa M; Mizuno T
    PLoS One; 2016; 11(1):e0147574. PubMed ID: 26812605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy.
    Compta Y; Giraldo DM; Muñoz E; Antonelli F; Fernández M; Bravo P; Soto M; Cámara A; Torres F; Martí MJ;
    Parkinsonism Relat Disord; 2018 Jan; 46():16-23. PubMed ID: 29107645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study.
    Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
    J Neurol Sci; 1996 Dec; 144(1-2):77-83. PubMed ID: 8994107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy.
    Bettencourt C; Foti SC; Miki Y; Botia J; Chatterjee A; Warner TT; Revesz T; Lashley T; Balazs R; Viré E; Holton JL
    Acta Neuropathol; 2020 Jan; 139(1):135-156. PubMed ID: 31535203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple system atrophy of the cerebellar type: clinical state of the art.
    Lin DJ; Hermann KL; Schmahmann JD
    Mov Disord; 2014 Mar; 29(3):294-304. PubMed ID: 24615754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Striatonigral degeneration and sporadic olivopontocerebellar atrophy: a consideration of the clinical entity of multiple system atrophy].
    Miwa H; Kondo T; Mizuno Y
    No To Shinkei; 1999 Apr; 51(4):305-12. PubMed ID: 10363264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review.
    Jiménez-Jiménez FJ; Alonso-Navarro H; García-Martín E; Agúndez JAG
    J Pers Med; 2022 Jun; 12(6):. PubMed ID: 35743757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in cerebellar perfusion between Parkinson's disease and multiple system atrophy.
    Murakami N; Sako W; Haji S; Furukawa T; Otomi Y; Otsuka H; Izumi Y; Harada M; Kaji R
    J Neurol Sci; 2020 Feb; 409():116627. PubMed ID: 31865188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems.
    Inoue M; Yagishita S; Ryo M; Hasegawa K; Amano N; Matsushita M
    Acta Neuropathol; 1997 Jun; 93(6):585-91. PubMed ID: 9194897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is multiple system atrophy with cerebellar ataxia (MSA-C) like spinocerebellar ataxia and multiple system atrophy with parkinsonism (MSA-P) like Parkinson's disease? - A saccade study on pathophysiology.
    Terao Y; Fukuda H; Tokushige S; Inomata-Terada S; Yugeta A; Hamada M; Ichikawa Y; Hanajima R; Ugawa Y
    Clin Neurophysiol; 2016 Feb; 127(2):1491-1502. PubMed ID: 26350408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopy (1H MRS) in patients with sporadic cerebellar degeneration.
    Terakawa H; Abe K; Watanabe Y; Nakamura M; Fujita N; Hirabuki N; Yanagihara T
    J Neuroimaging; 1999 Apr; 9(2):72-7. PubMed ID: 10208103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.